Rankings
▼
Calendar
RGEN FY 2014 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
FY 2014 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$64M
-6.8% YoY
Gross Profit
$36M
55.9% margin
Operating Income
$11M
16.8% margin
Net Income
$8M
12.9% margin
EPS (Diluted)
$0.25
Cash Flow
Operating Cash Flow
$18M
Free Cash Flow
$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
-$65M
Total Liabilities
$17M
Stockholders' Equity
$112M
Cash & Equivalents
$62M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$68M
-6.8%
Gross Profit
$36M
$43M
-17.4%
Operating Income
$11M
$23M
-53.3%
Net Income
$8M
$16M
-49.2%
← FY 2013
All Quarters
FY 2015 →